Suggest a new product or place a custom order.
| Name | Clone | Application | Cat. No. | Reg. | |
|---|---|---|---|---|---|
Anti-Human CD11b (activation epitope) FITC |
CBRM1/5 | FC | 11-0113 | RUO | |
Anti-Human CD11b FITC |
ICRF44 | FC | 11-0118 | RUO | |
Anti-Mouse CD11b FITC |
M1/70 | FC | 11-0112 | RUO | |
Anti-Human CD11c FITC |
3.9 | FC | 11-0116 | RUO | |
Anti-Mouse CD11c FITC |
N418 | FC | 11-0114 | RUO | |
Anti-Human CD13 FITC |
WM-15 (WM15) | FC | 11-0138 | RUO | |
Anti-Human CD14 FITC |
61D3 | FC | 11-0149 | RUO | |
CD14 FITC |
61D3 | FC | 8011-0149 | ASR | |
CD14 FITC |
61D3 | FC | 9011-0149 | CE | |
Anti-Mouse CD14 FITC |
Sa2-8 | FC | 11-0141 | RUO | |
Anti-Human CD15 FITC |
HI98 | FC | 11-0159 | RUO | |
CD15 FITC |
MMA | 8011-0158 | ASR | ||
CD15 FITC |
MMA | FC | 9011-0158 | CE | |
CD16 FITC |
CB16 | 8011-0168 | ASR | ||
CD16 FITC |
CB16 | FC | 9011-0168 | CE | |
Anti-Human CD16 FITC |
eBioCB16 (CB16) | FC | 11-0168 | RUO | |
Anti-Mouse CD16/CD32 FITC |
93 | FC | 11-0161 | RUO | |
Anti-Human/Non-Human Primate CD18 FITC |
6.7 | FC | 11-0189 | RUO | |
Anti-Mouse CD18 FITC |
M18/2 | FC | 11-0181 | RUO | |
Anti-Mouse CD19 FITC |
eBio1D3 (1D3) | FC | 11-0193 | RUO | |
Anti-Human CD19 FITC |
HIB19 | FC | 11-0199 | RUO | |
Anti-Mouse CD19 FITC |
MB19-1 | FC | 11-0191 | RUO | |
Anti-Human CD20 FITC |
2H7 | FC | 11-0209 | RUO | |
CD20 FITC |
2H7 | 8011-0209 | ASR | ||
CD20 FITC |
2H7 | FC | 9011-0209 | CE |
* = Please click on product link to see all available sizes and pricing.
FC = Flow Cytometry, Intracellular Staining/Flow Cytometry; ELISA = ELISA, ELISPOT, Multiplexing Immunoassays; ICC = Immunocytochemistry; IHC = Immunohistochemistry, Immunofluorescence, Microscopy, Imaging, In Vivo Imaging; FA = Functional Assays, Bioassays, Neutralization, Depletion Studies, Biomolecule Conjugation; WB = Immunoprecipitation, Western Blotting
RUO = Research Use Only; GPR = General Purpose Reagent; ASR = Analyte Specific Reagent. Analytical and performance characteristics are not established; CE = CE-marked reagents
